Market Overview:
The global exosomes market is expected to reach USD 1,711.8 million by 2030 from USD 564.5 million in 2018, at a CAGR of 16.9%. The growth of the market can be attributed to the increasing prevalence of chronic diseases, rising demand for personalized medicine, and technological advancements in exosome isolation and analysis techniques. However, the high cost associated with exosome-based therapies may restrain the growth of this market to some extent during the forecast period. Based on type, non-coding RNAs are expected to account for the largest share of the global exosomes market in 2018. This large share can be attributed to their ability to regulate gene expression and their potential use as biomarkers for various diseases.
Product Definition:
Exosomes are tiny vesicles (30-100 nm in diameter) that bud off from the membrane of cells. They are released into the extracellular environment and can carry proteins, lipids, and nucleic acids from one cell to another. Exosomes play an important role in cell-to-cell communication, helping to coordinate cellular activities and maintain tissue homeostasis.
Non-coding RNAs:
Non-coding RNAs (ncRNA) are RNA molecules that do not code for protein; however, they play an important role in the regulation of gene expression. They act as a substitute or companion to coding RNAs in certain processes such as post-translational modification of proteins and serve as biomarkers for identifying cellular functions.
The global non-coding RNA market size was valued at USD 861.6 million in 2016.
Lipids:
Lipids are naturally occurring organic compounds that include fats, waxes, sterols, fatty acids & phospholipids. They are insoluble in water and mostly soluble in alkali. Exosomes comprise of lipid components such as cholesterol (from animal sources), glycerol (as a source of hydroxyl groups) and sphingomyelin (a form of fat).
Application Insights:
The cancer segment dominated the global exosomes market in terms of revenue share in 2017. The growing prevalence of cancer is one of the major factors contributing to the large share held by this segment. According to WHO, it is estimated that globally 1 in 6 people will develop cancer during their lifetime and around 2 million deaths due to cancer are reported every year. Therefore, a huge unmet medical need pertaining to better treatment options for these diseases drives demand for exosomes-based therapeutics.
Exosomes have been proven effective against various types of cancers including lung, breast, prostate and liver among others which indicates their potential as a novel therapeutic tool against several cancers with no side effects or toxicity issues associated with them like other drugs do cause (tumor cell proliferation).
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its position during the forecast period owing to increasing R&D activities and high healthcare expenditure. In addition, supportive government initiatives pertaining to reimbursement of clinical trials are also anticipated to propel regional growth over the next eight years.
Asia Pacific is estimated to be one of the fastest-growing regions from 2018 to 2030 due bothto increasing R&D activities as well as rising patient awareness levels regarding advanced diagnostic techniques and availability of effective treatment options in emerging economies such as China & India & Australia etc.
Infectious diseases including cancer are among major causes for human suffering worldwide which has led researchers.
Growth Factors:
- Increasing demand for exosomes in regenerative medicine and drug delivery applications
- Growing research and development activities for the use of exosomes in novel therapeutic applications
- Rising number of collaborations and partnerships between pharmaceutical companies and biotechnology firms to develop exosome-based therapeutics
- Increasing investment by venture capitalists in startups focused on developing exosome-based therapies
- Proliferation of nanotechnology platforms that can be used to isolate, purify, and characterize exosomes
Scope Of The Report
Report Attributes
Report Details
Report Title
Exosomes Market Research Report
By Type
Non-coding RNAs, Lipids, mRNA, DNA fragments, Proteins /peptides
By Application
Cancer, Infectious diseases, Neurodegenerative diseases, Cardiovascular diseases
By Companies
Fujifilm, Thermo Fisher Scientific, Danaher, Illumina, Qiagen, Takara Bio, Malvern Instruments, Miltenyi Biotec, MBL International, Lonza
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Exosomes Market Report Segments:
The global Exosomes market is segmented on the basis of:
Types
Non-coding RNAs, Lipids, mRNA, DNA fragments, Proteins /peptides
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Infectious diseases, Neurodegenerative diseases, Cardiovascular diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fujifilm
- Thermo Fisher Scientific
- Danaher
- Illumina
- Qiagen
- Takara Bio
- Malvern Instruments
- Miltenyi Biotec
- MBL International
- Lonza
Highlights of The Exosomes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-coding RNAs
- Lipids
- mRNA
- DNA fragments
- Proteins /peptides
- By Application:
- Cancer
- Infectious diseases
- Neurodegenerative diseases
- Cardiovascular diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Exosomes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Exosomes are small vesicles that are released from cells and travel through the body. They can carry genetic material, proteins, and other molecules between cells.
Some of the major companies in the exosomes market are Fujifilm, Thermo Fisher Scientific, Danaher, Illumina, Qiagen, Takara Bio, Malvern Instruments, Miltenyi Biotec, MBL International, Lonza.
The exosomes market is expected to grow at a compound annual growth rate of 16.9%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Exosomes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Exosomes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Exosomes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Exosomes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Exosomes Market Size & Forecast, 2020-2028
4.5.1 Exosomes Market Size and Y-o-Y Growth
4.5.2 Exosomes Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Non-coding RNAs
5.2.2 Lipids
5.2.3 mRNA
5.2.4 DNA fragments
5.2.5 Proteins /peptides
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Infectious diseases
6.2.3 Neurodegenerative diseases
6.2.4 Cardiovascular diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Exosomes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Exosomes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Non-coding RNAs
9.6.2 Lipids
9.6.3 mRNA
9.6.4 DNA fragments
9.6.5 Proteins /peptides
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Infectious diseases
9.10.3 Neurodegenerative diseases
9.10.4 Cardiovascular diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Non-coding RNAs
10.6.2 Lipids
10.6.3 mRNA
10.6.4 DNA fragments
10.6.5 Proteins /peptides
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Infectious diseases
10.10.3 Neurodegenerative diseases
10.10.4 Cardiovascular diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Non-coding RNAs
11.6.2 Lipids
11.6.3 mRNA
11.6.4 DNA fragments
11.6.5 Proteins /peptides
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Infectious diseases
11.10.3 Neurodegenerative diseases
11.10.4 Cardiovascular diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Non-coding RNAs
12.6.2 Lipids
12.6.3 mRNA
12.6.4 DNA fragments
12.6.5 Proteins /peptides
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Infectious diseases
12.10.3 Neurodegenerative diseases
12.10.4 Cardiovascular diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Non-coding RNAs
13.6.2 Lipids
13.6.3 mRNA
13.6.4 DNA fragments
13.6.5 Proteins /peptides
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Infectious diseases
13.10.3 Neurodegenerative diseases
13.10.4 Cardiovascular diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Exosomes Market: Competitive Dashboard
14.2 Global Exosomes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fujifilm
14.3.2 Thermo Fisher Scientific
14.3.3 Danaher
14.3.4 Illumina
14.3.5 Qiagen
14.3.6 Takara Bio
14.3.7 Malvern Instruments
14.3.8 Miltenyi Biotec
14.3.9 MBL International
14.3.10 Lonza
